Synlogic Inc. is a biotechnology company that focuses on developing synthetic biotic medicines. Their innovative approach uses genetically engineered microbes to treat a range of diseases, such as metabolic disorders and cancer. With their cutting-edge technology and promising pipeline, Synlogic is poised to make a significant impact in the field of biopharmaceuticals.
Notification